Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InVivo Therapeutics Holdings Corp NVIVQ

Healthcare Medical Devices
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCIs). The Company's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. It is intended to promote appositional, or side-by... see more

Recent & Breaking News (PINL:NVIVQ)

InVivo Therapeutics Announces Conditional Approval for INSPIRE Pivotal Probable Benefit Clinical Study of the Neuro-Spinal Scaffold(TM)

Business Wire December 3, 2015

InVivo Therapeutics Announces Bioengineered Neural Trails(TM) Program for Chronic Spinal Cord Injury

Business Wire December 2, 2015

InVivo Therapeutics Announces Key Opinion Leader Event and Company Update with Robert Langer, Sc.D., and Nicholas Theodore, M.D.

Business Wire December 1, 2015

InVivo Therapeutics Announces Jay Blackington as New Vice President, Head of Human Resources

Business Wire November 25, 2015

Equity Market Movement at a Glance - Research on Noodles & Co, Corindus Vascular Robotics, InVivo Therapeutics Holdings and Jamba

Accesswire November 20, 2015

InVivo Therapeutics Reports 2015 Third Quarter Financial Results and Business Update

Business Wire November 4, 2015

InVivo Therapeutics Reports Significant Improvement of First Patient Implanted with Neuro-Spinal Scaffold(TM)

Business Wire October 23, 2015

InVivo Therapeutics Receives SEC Notice of Closing of Inquiry

Business Wire October 22, 2015

InVivo Therapeutics Announces Expansion of Number of Patients in Pilot Study

Business Wire October 19, 2015

InVivo Therapeutics to Present at the 2015 Aegis Growth Conference

Business Wire October 5, 2015

InVivo Therapeutics Featured in Bloomberg Businessweek Article

Business Wire October 2, 2015

InVivo Therapeutics to Present at the Stem Cell Meeting on the Mesa

Business Wire September 29, 2015

InVivo Therapeutics' CEO and Chairman, Mark Perrin, Featured in MedGadget Article

Business Wire September 28, 2015

InVivo Therapeutics to Present and Exhibit at the 65th CNS Annual Meeting

Business Wire September 21, 2015

InVivo Therapeutics' CEO and Chairman, Mark Perrin, Featured on DeviceTalks by MassDevice

Business Wire September 16, 2015

InVivo Therapeutics Featured as an Industry Innovator by MassBio

Business Wire September 10, 2015

InVivo Therapeutics Announces Mount Sinai Hospital in New York City as New Site for Neuro-Spinal Scaffold(TM) Clinical Trial

Business Wire September 9, 2015

InVivo Therapeutics Announces Enrollment of Fifth Patient in Pilot Spinal Cord Injury Study

Business Wire September 8, 2015

InVivo Therapeutics Co-Founder Dr. Robert Langer to Highlight InVivo Scientific Progress in Keynote at 2015 TERMIS World Congress

Business Wire September 2, 2015

InVivo Therapeutics to Present at Rodman & Renshaw 17th Annual Global Investment Conference

Business Wire September 1, 2015